Demonstrating scientific validity, analytical performance, and clinical efficacy of diagnostic algorithms.
EU MDR requires manufacturers to demonstrate clear clinical benefit through clinical investigations or peer-reviewed clinical equivalence studies on statistically significant cohorts.
Real-world telemetry feeds into continuous PMCF plans to confirm that the diagnostic algorithm maintains its sensitivity across changing patient populations.